Simufilam dismantles this prominent AD pathogenic pathway by disrupting the linkage of FLNA with α7nAChR, an interaction critical both to the toxic signaling and to the ultra-high-affinity binding of Aβ42 [9]. Here, CHRNA7 is linked to Alzheimer disease.